Connacht Asset Management’s NEVRO CORP. NVRO Stock Holding History

Connacht Asset Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,505	Closed	-$548K	–	173
2022 Q2	$548K	Sell	12,505 -6,257	-33%	-$344K	0.23%	92
2022 Q1	$1.36M	Sell	18,762 -3,467	-16%	-$250K	0.69%	36
2021 Q4	$1.8M	Buy	22,229 +8,674	+64%	+$869K	1.76%	17
2021 Q3	$1.58M	Buy	+13,555	New	+$1.77M	1.02%	32

Other funds holding NVRO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Connacht Asset Management's NVRO Position: Q3 2022 in Review

Connacht Asset Management sold out of NEVRO CORP. (NVRO) in Q3 2022, closing a stake of 12,505 shares — an estimated $548K sold.

Connacht Asset Management first reported a position in NVRO in Q3 2021 and held it in 4 quarters. The position peaked at $1.8M in Q4 2021. 177 funds tracked by Wall St. Rank hold NVRO as of Q3 2022.

Connacht Asset Management reported no remaining NEVRO CORP. position as of Q3 2022 after selling out during the quarter.
Connacht Asset Management sold 12,505 NEVRO CORP. shares in Q3 2022, an estimated $548K.
Connacht Asset Management first reported a position in NEVRO CORP. in Q3 2021 and held it in 4 quarters.
Connacht Asset Management's NEVRO CORP. position peaked at $1.8M in Q4 2021.
177 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2022.

Based on Connacht Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.